CSat Investment Advisory’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $63K | Buy |
197
+6
| +3% | +$1.92K | 0.05% | 145 |
|
2020
Q4 | $62K | Sell |
191
-150
| -44% | -$48.7K | 0.06% | 123 |
|
2020
Q3 | $95K | Buy |
341
+1
| +0.3% | +$279 | 0.01% | 483 |
|
2020
Q2 | $82K | Sell |
340
-154
| -31% | -$37.1K | 0.01% | 544 |
|
2020
Q1 | $72K | Buy |
494
+72
| +17% | +$10.5K | 0.02% | 428 |
|
2019
Q4 | $72K | Buy |
422
+78
| +23% | +$13.3K | 0.02% | 476 |
|
2019
Q3 | $61K | Buy |
344
+108
| +46% | +$19.2K | 0.02% | 438 |
|
2019
Q2 | $62K | Buy |
236
+174
| +281% | +$45.7K | 0.02% | 406 |
|
2019
Q1 | $18K | Buy |
62
+8
| +15% | +$2.32K | 0.01% | 339 |
|
2018
Q4 | $18K | Buy |
54
+22
| +69% | +$7.33K | 0.01% | 316 |
|
2018
Q3 | $14K | Buy |
32
+8
| +33% | +$3.5K | 0.01% | 305 |
|
2018
Q2 | $10K | Buy |
+24
| New | +$10K | 0.01% | 361 |
|